AzTrials
AzTrials

Hearing LossFunCoSyNCT06556160

Fundamental and Clinical Study of Cochlear Synaptopathy

A study testing near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode in people with Hearing Loss, run by CHU de Reims at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In humans, surface electrophysiological recording of the cochlear nerve in response to a sound stimulus provides information about the integrity and function of synapses (synaptic transmission) and nerve fibre function. However, this information remains global. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Hearing Loss
What is being tested?
near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteFrance
Study dates
21 Mar 2023to 4 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with normal hearing will be included:
  • male or female
  • over 18 and up to 70 years of age
  • normal otoscopic examination
  • due to undergo surgery on the cerebellopontine angle (microvascular decompression).
  • free of neuro-sensory deafness, defined by mean hearing thresholds of less than or equal to 20 dB HL in pure tone audiometry in air conduction bilaterally on the side of the ear operated on and on the non-operated side from 0.25 to 8 kHz
Show all 15Show fewer
  • affiliated to a social security scheme
  • have read the information note describing the study and have agreed in writing to take part by signing the informed consent form.
  • Patients with a hearing impairment will be included:
  • male or female
  • over 18 and up to 70 years of age
  • normal otoscopic examination
  • due to undergo surgery on the cerebellopontine angle (microvascular decompression).
  • have a sensorineural hearing loss defined by hearing thresholds of 20 dB HL or better from 0.25 to 2 kHz and from 20 dB HL excluded to 55 dB HL at frequencies above 2 kHz.
  • have read the information note describing the study and have agreed in writing to take part by signing the informed consent form.

Who cannot join

  • Patients will be excluded from the study for whom the auditory nerve is not accessible during surgery, in particular because of complete tumour invasion of the cochlear nerve (stage III and IV neuroma, advanced meningioma) or because of a particular anatomical feature not identified during the preoperative examination, making it impossible to expose the nerve for recordings (protrusion of the posterior surface of the rock).

Trial locations and contacts

1 site in 1 country.

France1 site
  • Damien JOLLY

    Reims

Other trials in France

About this study

Official title: Basic and Clinical Studies of Cochlear Synaptopathy

In humans, surface electrophysiological recording of the cochlear nerve in response to a sound stimulus provides information about the integrity and function of synapses (synaptic transmission) and nerve fibre function. However, this information remains global. The investigators have preliminary data showing that it is possible to extract and characterise the functional properties of nerve fibres during otoneurosurgery in humans, and therefore to isolate the neuronal sub-populations mentioned above more precisely than is currently possible. The use of these electrophysiological data from near-field recordings, i.e. in contact with the nerve, will enable the design and improvement of a mathematical model of the human cochlea. This model will provide access to the individual responses of each nerve fibre and fill the current gap in knowledge between the functioning of these fibres and global surface recordings.

Read the detailed description

During functional surgery on the cerebellopontine angle, a ball electrode is placed on the human cochlear nerve to monitor hearing. Once the electrode is in place, clicks and random noise bands will be delivered in order to analyze the cochlear electrophysiological signal produced. Depending on the characteristics recorded, this signal can be used at a given frequency and intensity to identify the populations of auditory neurons mainly involved. Prior to surgery, each patient will have been examined by the audiologist in order to determine the auditory thresholds in silence and noise, in tone and in speech, to carry out the digit test and to perform an electrocochleography and distortion products. Each result analyzed will be the subject of a further analysis using the mathematic model of the human cochlea.

Conditions
Hearing Loss
Being tested
near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode
Keywords
Hearing Loss, Deafness, Micro vascular decompression, otoneurosurgery, retrosigmoid approach
Medical subject headings
Hearing Loss, Deafness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • near field recording of human auditory nerve activity during retro sigmoid approach with contact electrodeProcedure or surgery

    During surgery using a retro-sigmoid approach in the cerebellopontine angle (microvascular decompression), near-field recording of human auditory nerve activity using a contact electrode is performed on patients with normal or impaired hearing threshold.

    Each patient is explored preoperatively by hearing tests to search synaptopathie. During the surgery, stimuli are delivered.

Study groups in NCT06556160
Study groupRoleWhat they receive
hearing impaired patientsExperimentalhave a sensorineural hearing loss defined by hearing thresholds of 20 dB HL or better from 0.25 to 2 kHz and from 20 dB HL excluded to 55 dB HL at frequencies above 2 kHz.
Receives: Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode
normal hearing patientsActive comparatorfree of neuro-sensory deafness, defined by mean hearing thresholds of less than or equal to 20 dB HL in pure tone audiometry in air conduction bilaterally on the side of the ear operated on and on the non-operated side from 0.25 to 8 kHz
Receives: Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In response to a stimulus, the neurophonic potential recorded in the form of a wave called PSTR will be characterised patients defined as normo and hearing loss based on preoperative audiometric tests

    During ponto cerebellum retro sigmoide surgery. In response to a stimulus, the neurophonic potential recorded in the form of a wave called PSTR will be characterised patients defined as normo and hearing loss based on preoperative audiometric tests by the following indices:- the amplitude of the peak- the amplitude of the plateau- the peak to plateau ratio- the time constant for the rapid decay of the peak- the time constant for the slow decay of the peak.

    Measured: At 48 months

  2. Compare the amplitude and spectrum of global evoked auditory nerve activity with basic stimuli between patients defined as normo and hearing loss based on preoperative audiometric tests

    During ponto cerebellum retro sigmoide surgeryelectrocochleography and distortion products.

    Measured: At 48 months

Secondary outcomes (1)
  1. compare the primary objective with the results obtained with a mathematical model of the human cochlea in order to improve the responses of our model.

    During ponto cerebellum retro sigmoide surgery

    Measured: At 48 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2024
  2. Study start21 Mar 2023
  3. Primary completion16 Jul 2025
  4. Study completion4 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06556160
Sponsor's protocol ID
PO23045
Acronym
FunCoSy
Status last verified
Dec 2025
First submitted
17 Aug 2023
Last updated
18 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode in people with Hearing Loss, run by CHU de Reims at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In response to a stimulus, the neurophonic potential recorded in the form of a wave called PSTR will be characterised patients defined as normo and hearing loss based on preoperative audiometric tests (time frame: At 48 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in